Previous Page Table of Contents Next Page


Contributors

(MEETING PARTICIPANTS)

EXPERTS

Dr Colin Block, Hadassah-Hebrew University Medical Centres, Israel

Dr Christopher Braden, National Center for Infectious Diseases, United States of America

Dr Robert Buchanan, US Food and Drug Administration, United States of America

Dr Celia Carlos, Department of Health, the Philippines

Prof. Martin Cole, Food Science Australia, Australia

Dr John Cowden, Scottish Centre for Infection and Environmental Health, United Kingdom

Dr Jeff Farber, Health Canada, Canada

Dr Stephen J. Forsythe, Nottingham Trent University, United Kingdom

Dr Arie Havelaar,[1] National Institute of Public Health and the Environment, the Netherlands, and WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water

Dr Shizunobu Igimi, National Institute of Health Sciences, Japan

Dr Lisa Lefferts, Consultant, United States of America

Dr Harry Muytjens, University Medical Center Nijmegen, the Netherlands

Dr Gopinath Balakrish Nair, International Centre for Diarrheal Disease Research, Bangladesh

Mr Greg Paoli, Decisionalysis Risk Consultants, Inc., Canada

Prof. Hildegard Przyrembel, Federal Institute for Risk Assessment (BfR), Germany

Dr Jos Van Acker, AZ Sint-Lucas/Volkskliniek Laboratory, Belgium

Dr Marcel Zwietering, Wageningen University and Research Center, the Netherlands

PARTICIPANTS FROM INDUSTRY FOR GENERAL INFORMATION EXCHANGE

Dr Jean-Louis Cordier, Nestec S.A., Switzerland

Mr Daniel March, Mead Johnson Nutritionals, United States of America

DECLARATIONS OF INTEREST

Two out of the 16 experts which participated in this meeting declared an interest in the topics under consideration:

Dr Forsythe: His research is related to a commercially available tool for diagnosis of Enterobacter sakazakii in infant formula.

Dr Zwietering: His unit at the University of Wageningen performs scientific research which is financially supported by a company producing powdered infant formula.


[1] Convener of the pre-meeting electronic discussion group to consider possible approaches for assessing the risk posed by pathogens in powdered infant formula.

Previous Page Top of Page Next Page